COVID-19 vaccine and mRNA technology: spreading the knowledge
Client: Biotech Research company
Services: Translation and Localization
Language pair: English into Portuguese
Volume: 90,000 words
Translation Memories and Quality Control technologies: SDL Studio and Xbench
I have been helping a leading pharmaceutical and biotechnology company spread the knowledge regarding their FDA and EMA-approved mRNA-based vaccine that eventually would help to mitigate the pandemic situation of COVID-19.
A publicly traded leading Pharmaceutical and Biotechnology company based in Cambridge (USA) pioneering a new class of medicines made of mRNA and focusing on RNA therapeutics, primarily mRNA vaccines.